- Home
- SOHU vs RNAC Comparison
SOHU vs RNAC Comparison
Compare SOHU & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- RNAC
- Stock Information
- Founded
- SOHU 1996
- RNAC 2007
- Country
- SOHU China
- RNAC United States
- Employees
- SOHU N/A
- RNAC N/A
- Industry
- SOHU EDP Services
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- RNAC Health Care
- Exchange
- SOHU Nasdaq
- RNAC Nasdaq
- Market Cap
- SOHU 319.0M
- RNAC 276.3M
- IPO Year
- SOHU 2000
- RNAC 2016
- Fundamental
- Price
- SOHU $16.08
- RNAC $10.05
- Analyst Decision
- SOHU Strong Buy
- RNAC Strong Buy
- Analyst Count
- SOHU 1
- RNAC 4
- Target Price
- SOHU $20.00
- RNAC $40.00
- AVG Volume (30 Days)
- SOHU 74.0K
- RNAC 48.4K
- Earning Date
- SOHU 08-04-2025
- RNAC 08-07-2025
- Dividend Yield
- SOHU N/A
- RNAC N/A
- EPS Growth
- SOHU N/A
- RNAC N/A
- EPS
- SOHU 4.10
- RNAC N/A
- Revenue
- SOHU $548,588,000.00
- RNAC $1,026,000.00
- Revenue This Year
- SOHU N/A
- RNAC N/A
- Revenue Next Year
- SOHU $2.29
- RNAC N/A
- P/E Ratio
- SOHU $3.92
- RNAC N/A
- Revenue Growth
- SOHU N/A
- RNAC N/A
- 52 Week Low
- SOHU $7.79
- RNAC $8.46
- 52 Week High
- SOHU $17.24
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- SOHU 60.31
- RNAC 34.71
- Support Level
- SOHU $14.92
- RNAC $10.50
- Resistance Level
- SOHU $16.45
- RNAC $11.80
- Average True Range (ATR)
- SOHU 0.53
- RNAC 0.56
- MACD
- SOHU -0.02
- RNAC -0.11
- Stochastic Oscillator
- SOHU 76.99
- RNAC 0.45
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.